{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:04:58Z","timestamp":1793189098653,"version":"4.5.0"},"reference-count":43,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Trudell medical international, London, Canada","award":["Investigator initiated study"],"award-info":[{"award-number":["Investigator initiated study"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,8,25]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Airway clearance is a fundamental component of bronchiectasis care. Lung clearance index (LCI) is a measurement of ventilation inhomogeneity. Its responsiveness to long-term airway clearance is unknown. We aimed to compare two methods of daily airway clearance over 4\u2005weeks: autogenic drainage (AD) and oscillating positive airway pressure (oPEP), and to determine effects of airway clearance on LCI and clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adults with bronchiectasis naive to airway clearance were randomised to daily airway clearance with either AD or oPEP. Difference in LCI as primary outcome, spirometry, sputum volume and purulence, and quality of life were at randomisation and after 4\u2005weeks of airway clearance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>51 patients (32 women and 19 men, mean age 66.2\u00b112.8\u2005years) were randomised and 49 completed the study (25 AD and 24 oPEP). The LCI and forced expiratory volume in 1\u2005s did not change between visits between groups (difference between groups 0.02), nor between visits in either group. Sputum quantity decreased in 12 out of 24 (50%) of the oPEP group, and in six out of 25 (24%) of the AD group (p=0.044). The \u201ctreatment burden\u201d worsened or was unchanged in 70% of participants randomised to AD and 55% randomised to oPEP (p=0.038).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sputum quantity decreased in more participants randomised to oPEP group after 1\u2005month of daily airway clearance, with a better treatment burden. The effects of 4\u2005weeks of airway clearance on LCI were not significant in either treatment group.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00426-2021","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T15:45:44Z","timestamp":1631202344000},"page":"00426-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["4-week daily airway clearance using oscillating positive-end expiratory pressure<i>versus<\/i>autogenic drainage in bronchiectasis patients: a randomised controlled trial"],"prefix":"10.1183","volume":"7","author":[{"given":"Galit","family":"Livnat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nili","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Bentur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneera","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yochai","family":"Adir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-3398","authenticated-orcid":false,"given":"Michal","family":"Shteinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"2024101711212190000_7.4.00426-2021.1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"2024101711212190000_7.4.00426-2021.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0051-2019"},{"key":"2024101711212190000_7.4.00426-2021.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101711212190000_7.4.00426-2021.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01610-2019"},{"key":"2024101711212190000_7.4.00426-2021.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055509"},{"key":"2024101711212190000_7.4.00426-2021.6","doi-asserted-by":"publisher","DOI":"10.1002\/pri.507"},{"key":"2024101711212190000_7.4.00426-2021.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2012.03.001"},{"key":"2024101711212190000_7.4.00426-2021.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00069712"},{"key":"2024101711212190000_7.4.00426-2021.9","doi-asserted-by":"crossref","first-page":"e1667","DOI":"10.1002\/pri.1667","article-title":"Non-invasive ventilation as airway clearance technique in cystic fibrosis","volume":"22","author":"Rodriguez Hortal","year":"2017","journal-title":"Physiother Res Int"},{"key":"2024101711212190000_7.4.00426-2021.10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.201807-1203OC","article-title":"Preventive inhalation of hypertonic saline in infants with cystic fibrosis (PRESIS): a randomized, double-blind, controlled study","volume":"199","author":"Stahl","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711212190000_7.4.00426-2021.11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S2213-2600(19)30187-0","article-title":"Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"7","author":"Ratjen","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101711212190000_7.4.00426-2021.12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ppul.23670","article-title":"Chest physiotherapy can affect the lung clearance index in cystic fibrosis patients","volume":"52","author":"Grosse-Onnebrink","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2024101711212190000_7.4.00426-2021.13","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-59"},{"key":"2024101711212190000_7.4.00426-2021.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00152-2015"},{"key":"2024101711212190000_7.4.00426-2021.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1747OC"},{"key":"2024101711212190000_7.4.00426-2021.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.01.025"},{"key":"2024101711212190000_7.4.00426-2021.17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.rmed.2014.03.011","article-title":"Tracking Lung Clearance Index and chest CT in mild cystic fibrosis lung disease over a period of three years","volume":"108","author":"Fuchs","year":"2014","journal-title":"Respir Med"},{"key":"2024101711212190000_7.4.00426-2021.18","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.150375"},{"key":"2024101711212190000_7.4.00426-2021.19","unstructured":"Trudell Medical International. AEROBIKA* OPEP Device. www.trudellmed.com\/products\/aerobika-opep-device Date last accessed: 24 April 2020."},{"key":"2024101711212190000_7.4.00426-2021.20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15412555.2015.1043523","article-title":"Oscillatory positive expiratory pressure in chronic obstructive pulmonary disease","volume":"13","author":"Svenningsen","year":"2016","journal-title":"COPD"},{"key":"2024101711212190000_7.4.00426-2021.21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s41030-018-0055-9","article-title":"A real-world evidence study assessing the impact of adding the Aerobika oscillating positive expiratory pressure device to standard of care upon healthcare resource utilization and costs in post-operative patients","volume":"4","author":"Burudpakdee","year":"2018","journal-title":"Pulm Ther"},{"key":"2024101711212190000_7.4.00426-2021.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.14614189"},{"key":"2024101711212190000_7.4.00426-2021.23","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05194"},{"key":"2024101711212190000_7.4.00426-2021.24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/resp.13459","article-title":"Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis","volume":"24","author":"O'Neill","year":"2019","journal-title":"Respirology"},{"key":"2024101711212190000_7.4.00426-2021.25","doi-asserted-by":"crossref","unstructured":"Lee AL , Burge AT , Holland AE . Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015; 11: CD008351. doi:10.1002\/14651858.CD008351.pub3","DOI":"10.1002\/14651858.CD008351.pub3"},{"key":"2024101711212190000_7.4.00426-2021.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1891"},{"key":"2024101711212190000_7.4.00426-2021.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2024101711212190000_7.4.00426-2021.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00163208"},{"key":"2024101711212190000_7.4.00426-2021.29","first-page":"PA3349","article-title":"Validation of a four point sputum colour chart in chronic obstructive pulmonary disease","volume":"46","author":"McKane","year":"2015","journal-title":"Eur Respir J"},{"key":"2024101711212190000_7.4.00426-2021.30","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20825"},{"key":"2024101711212190000_7.4.00426-2021.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.09.005"},{"key":"2024101711212190000_7.4.00426-2021.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2024101711212190000_7.4.00426-2021.33","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205918"},{"key":"2024101711212190000_7.4.00426-2021.34","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205587"},{"key":"2024101711212190000_7.4.00426-2021.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1763"},{"key":"2024101711212190000_7.4.00426-2021.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071312"},{"key":"2024101711212190000_7.4.00426-2021.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.12.009"},{"key":"2024101711212190000_7.4.00426-2021.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"2024101711212190000_7.4.00426-2021.39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/resp.12375","article-title":"Efficacy of azithromycin in the treatment of bronchiectasis","volume":"19","author":"Lourdesamy Anthony","year":"2014","journal-title":"Respirology"},{"key":"2024101711212190000_7.4.00426-2021.40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pupt.2019.03.009","article-title":"Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: a randomized controlled trial","volume":"56","author":"Watz","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"2024101711212190000_7.4.00426-2021.41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711212190000_7.4.00426-2021.42","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.pupt.2019.101834","article-title":"Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: design of a dose-finding study (iBEST-1)","volume":"58","author":"Loebinger","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"2024101711212190000_7.4.00426-2021.43","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00363-2019"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00426-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:11:57Z","timestamp":1740373917000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00426-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,8]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1183\/23120541.00426-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00426-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}